Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults-Reference-Cited by-同舟云学术

Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults

Published:2018-08-02 Issue:2 Volume:99 Page:338-349
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Jongo Said A.¹,Shekalaghe Seif A.¹,Church L. W. Preston²,Ruben Adam J.²,Schindler Tobias³⁴,Zenklusen Isabelle³⁴,Rutishauser Tobias³⁴,Rothen Julian³⁴,Tumbo Anneth¹,Mkindi Catherine¹,Mpina Maximillian¹,Mtoro Ali T.¹,Ishizuka Andrew S.⁵,Kassim Kamaka Ramadhani¹,Milando Florence A.¹,Qassim Munira¹,Juma Omar A.¹,Mwakasungula Solomon¹,Simon Beatus¹,James Eric R.²,Abebe Yonas²,KC Natasha²,Chakravarty Sumana²,Saverino Elizabeth²,Bakari Bakari M.¹,Billingsley Peter F.²,Seder Robert A.⁵,Daubenberger Claudia³⁴,Sim B. Kim Lee⁶²,Richie Thomas L.²,Tanner Marcel³⁴,Abdulla Salim¹,Hoffman Stephen L.²

Affiliation:

1. Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania;

2. Sanaria Inc., Rockville, Maryland;

3. University of Basel, Basel, Switzerland;

4. Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland;

5. Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;

6. Protein Potential LLC, Rockville, Maryland

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference36 articles.